Liraglutide Decreases Liver Fat Content and Serum Fibroblast Growth Factor 21 Levels in Newly Diagnosed Overweight Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

Table 2

Associations between FGF21 and various factors at baseline in all subjects.

Age	-0.252	0.121
Weight	0.032	0.848
BMI	0.088	0.596
Waist circumference	0.232	0.156
FBG	0.575	<0.001
2 hPBG	0.515	0.001
FINS	0.808	<0.001
HOMA-IR	0.788	<0.001
HbA1c	0.857	<0.001
TCH	0.389	0.014
HDL	-0.383	0.016
LDL	0.136	0.408
TG	0.286	0.078
ALT	0.649	<0.001
AST	0.591	<0.001
ALP	0.189	0.250
GGT	0.537	<0.001
Liver fat content	0.717	<0.001

Abbreviations: BMI: body mass index; FBG: fasting blood glucose; 2 hPBG: 2-hour postprandial blood glucose; FINS: fasting insulin; HOMA-IR: homeostasis model assessment of insulin resistance; HbA1c: glycated hemoglobin; TC: total cholesterol; HDL: high-density lipoprotein cholesterol; TG: triglyceride; LDL: low-density lipoprotein cholesterol; ALT: alanine amino transferase; AST: aspartate aminotransferase; ALP: alkaline phosphatase; GGT: γ-glutamyl transferase; FGF21: fibroblast growth factor 21. ; .